$BCAX
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
Healthcare
Sector
Biotechnology
Industry
Ryan Cohlhepp
CEO
55
Employees
$18.41
Current Price
$896.78M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 5 | $528,079.44 | 27,500 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 6 | $1,232,736.60 | 64,266 | ||
| 1 month | Buys | 1 | 1 | $4,800,000.00 | 300,000 | 2.02:1 |
| Sells | 4 | 17 | $2,375,036.66 | 126,541 | ||
| 2 months | Buys | 1 | 1 | $4,800,000.00 | 300,000 | 1.94:1 |
| Sells | 4 | 19 | $2,478,495.09 | 132,251 | ||
| 3 months | Buys | 1 | 1 | $4,800,000.00 | 300,000 | 1.93:1 |
| Sells | 4 | 20 | $2,481,180.07 | 132,400 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | Hyep Ivan Chief Financial Officer | Sale | 1,882 | $18.15 | $34,162.44 | View Details |
| Jan 15, 2026 | Cohlhepp Ryan Director | Sale | 149 | $18.02 | $2,684.98 | View Details |
| Dec 22, 2025 | Hyep Ivan Chief Financial Officer | Sale | 9,200 | $18.31 | $168,491.56 | View Details |
27 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 21โ23 of 23 transactions
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.67
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$CDTX โ Cidara Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$WVE โ Wave Life Sciences Ltd.via RA CAPITAL MANAGEMENT, L.P.$CLYM โ Climb Bio, Inc.via RA CAPITAL MANAGEMENT, L.P.$SGP โ SpyGlass Pharma, Inc. Common Stockvia RA CAPITAL MANAGEMENT, L.P.$HOWL โ Werewolf Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.$PEPG โ PepGen Inc.via RA CAPITAL MANAGEMENT, L.P.$TYRA โ Tyra Biosciences, Inc.via RA CAPITAL MANAGEMENT, L.P.$MLYS โ Mineralys Therapeutics, Inc.via RA CAPITAL MANAGEMENT, L.P.